
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-03-02 | Thermopylae Holdings Ltd. | 10% Owner | Purchase | 38.0K | $3.44 | $131K | 56.13M | View ↗ | |
| 2026-02-27 | 2026-02-27 | Booth Andrew | Chief Financial Officer | Purchase | 42.6K | $3.42 | $146K | 195.6K | View ↗ | |
| 2026-02-26 | 2026-02-27 | Thermopylae Holdings Ltd. | 10% Owner | Purchase | 177.5K | $3.27 | $580K | 56.10M | View ↗ |
No annual data found.
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Why AbCellera Biologics (ABCL) Is Up 16.1% After ABCL635 Trial Momentum Builds Ahead Of Data
AbCellera to Present at Upcoming Investor Conferences in May and June 2026
JonesResearch Reiterates Buy on AbCellera Biologics (ABCL)